Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Wedmont Private Capital

Wedmont Private Capital lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,102 shares of the medical equipment provider’s stock after purchasing an additional 431 shares during the quarter. Wedmont Private Capital’s holdings in Intuitive Surgical were worth $3,341,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Fragasso Financial Advisors Inc grew its position in shares of Intuitive Surgical by 3.0% during the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock worth $359,000 after acquiring an additional 20 shares during the last quarter. Kieckhefer Group LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $5,632,000. Capital Investment Advisors LLC increased its stake in Intuitive Surgical by 15.6% in the fourth quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock valued at $469,000 after purchasing an additional 121 shares during the period. Brookstone Capital Management boosted its stake in shares of Intuitive Surgical by 25.4% during the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock worth $9,448,000 after buying an additional 3,663 shares during the period. Finally, Fiduciary Alliance LLC increased its position in Intuitive Surgical by 33.7% in the 4th quarter. Fiduciary Alliance LLC now owns 12,497 shares of the medical equipment provider’s stock valued at $6,523,000 after acquiring an additional 3,151 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares in the company, valued at $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 in the last three months. 0.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ISRG. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Raymond James lifted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Finally, The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Stock Down 1.8 %

Shares of ISRG stock traded down $10.10 during trading hours on Monday, hitting $537.37. 720,946 shares of the company were exchanged, compared to its average volume of 1,247,569. The firm has a fifty day moving average of $535.93 and a 200 day moving average of $495.17. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23. The firm has a market cap of $191.40 billion, a PE ratio of 86.39, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.